Miromatrix Stock Analysis

The latest indifference towards the small price fluctuations of Miromatrix Medical may encourage institutional investors to take a closer look at the firm as it is trading at a share price of 0.0 on very low momentum in trading volume. The company management teams did not add any value to Miromatrix Medical investors in April. However, most investors can still diversify their portfolios with Miromatrix Medical to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to institutional investors with longer-term investment horizons.
Check out Stocks Correlation.
  
Refresh
The Miromatrix Medical stock analysis report makes it easy to digest most publicly released information about Miromatrix Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Miromatrix Stock analysis module also helps to analyze the Miromatrix Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Miromatrix Stock Analysis Notes

About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Miromatrix Medical recorded a loss per share of 1.49. The entity had not issued any dividends in recent years. Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota. Miromatrix Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people. To find out more about Miromatrix Medical contact the company at 952 942 6000 or learn more at https://www.miromatrix.com.

Miromatrix Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Miromatrix Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Miromatrix Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Miromatrix Medical is not yet fully synchronised with the market data
Miromatrix Medical has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 33.07 K. Net Loss for the year was (14.67 M) with loss before overhead, payroll, taxes, and interest of (466.93 K).
Miromatrix Medical currently holds about 52.81 M in cash with (14.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57.
Miromatrix Medical has a poor financial position based on the latest SEC disclosures
Roughly 27.0% of the company outstanding shares are owned by corporate insiders

Miromatrix Medical Upcoming and Recent Events

Earnings reports are used by Miromatrix Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Miromatrix Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of February 2022
Next Fiscal Quarter End31st of December 2021

Miromatrix Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Miromatrix Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Miromatrix Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Miromatrix Medical specific information freely available to individual and institutional investors to make a timely investment decision.
16th of May 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
View
30th of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
1st of March 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
16th of February 2022
Unclassified Corporate Event
View
14th of February 2022
Unclassified Corporate Event
View
11th of February 2022
Unclassified Corporate Event
View
5th of January 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
17th of December 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View

Miromatrix Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Miromatrix Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Miromatrix Medical backward and forwards among themselves. Miromatrix Medical's institutional investor refers to the entity that pools money to purchase Miromatrix Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Gagnon Securities LlcCommon Shares849.1 K3.4 M
G2 Investment Partners Management LlcCommon Shares593.3 K2.3 M
First Light Asset Management LlcCommon Shares512.3 KM
Gagnon Advisors LlcCommon Shares459.6 K1.8 M
Rtw Investments LpCommon Shares280 K1.1 M
Vanguard Group IncCommon Shares169.9 K673 K
Stillwater Investment Management LlcCommon Shares90.1 K357 K
Note, although Miromatrix Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Miromatrix Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 76.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Miromatrix Medical's market, we take the total number of its shares issued and multiply it by Miromatrix Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Miromatrix Profitablity

Miromatrix Medical's profitability indicators refer to fundamental financial ratios that showcase Miromatrix Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Miromatrix Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Miromatrix Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Miromatrix Medical's profitability requires more research than a typical breakdown of Miromatrix Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.30) (0.32) 
Return on Average Equity(0.47) (0.48) 
Return on Invested Capital(41.27) (42.36) 
Return on Sales(425.12) (436.30) 

Management Efficiency

The entity has return on total asset (ROA) of (32.03) % which means that it has lost $32.03 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (58.97) %, meaning that it created substantial loss on money invested by shareholders. Miromatrix Medical management efficiency ratios could be used to measure how well miromatrix medical manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Average Assets is estimated to slide to -0.32. The value of Return on Average Equity is estimated to slide to -0.48. Miromatrix Medical Total Assets are quite stable at the moment as compared to the past year. The company's current value of Total Assets is estimated at 65.74 Million. Current Assets is expected to rise to about 59.7 M this year, although the value of Assets Non Current will most likely fall to about 4.9 M.
Last ReportedProjected for 2022
Book Value per Share 4.71  5.09 
Enterprise Value over EBIT(1.80) (1.94) 
Enterprise Value over EBITDA(2.19) (2.36) 
Price to Book Value 1.58  1.57 
Tangible Assets Book Value per Share 5.30  5.01 
Enterprise Value30.4 M30.2 M
Tangible Asset Value60.9 M65.7 M

Miromatrix Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Miromatrix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Miromatrix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Miromatrix Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Miromatrix Medical Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Miromatrix Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Bond Directory Now

   

Bond Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module
Additionally, see Stocks Correlation. Note that the Miromatrix Medical information on this page should be used as a complementary analysis to other Miromatrix Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for Miromatrix Stock

When running Miromatrix Medical price analysis, check to measure Miromatrix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Miromatrix Medical is operating at the current time. Most of Miromatrix Medical's value examination focuses on studying past and present price action to predict the probability of Miromatrix Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Miromatrix Medical's price. Additionally, you may evaluate how the addition of Miromatrix Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go